aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Vaxess Technologies, Inc., founded by four Harvard graduate students, is a Massachusetts-based biotechnology firm dedicated to revolutionizing vaccine delivery. Their core mission is to enhance global vaccine access through the MIMIX sustained dermal delivery platform, which offers high temperature stability, improved efficacy, and simplified administration. Vaxess envisions a future where vaccines and therapeutics can be self-administered without needles or refrigeration, making healthcare more convenient and accessible, particularly in low-resource settings.
Notable affiliates include the founding team from Harvard, and the company has attracted significant attention from investors in the biotech sector. Key achievements include the development of their innovative MIMIX platform, which has the potential to transform vaccine and therapeutic delivery worldwide. Vaxess's impact lies in its potential to make healthcare more equitable by addressing logistical challenges in vaccine distribution and administration, ultimately aiming to improve public health outcomes on a global scale.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Therapeutics, Vaccines
Technology
Biotech
Tags
Healthtech
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
United States
When was Vaxess Technologies founded?
Vaxess Technologies was founded in 2011.
Where is Vaxess Technologies’s headquarters located?
Vaxess Technologies’s headquarters is located in Cambridge, MA, US.
When was Vaxess Technologies’s last funding round?
Vaxess Technologies’s most recent funding round was for $9M (USD) in September 2023.
How many employees does Vaxess Technologies have?
Vaxess Technologies has 42 employees as of Feb 5, 2024.
How much has Vaxess Technologies raised to-date?
As of July 05, 2023, Vaxess Technologies has raised a total of $74.9M (USD) since Sep 13, 2023.
Add Comparison
Total Raised to Date
$74.9M
USD
Last Update Sep 13, 2023
Last Deal Details
$9M
USD
Sep 13, 2023
Series Unknown
Total Employees Over Time
42
As of Feb 2024
Vaxess Technologies Address
700 Main St
Cambridge,
Massachusetts
02139
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts